相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally from 2016-2017
Sarah M. McLeod et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases
Ruslan Tsivkovski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii
Olga Lomovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases
Olga Lomovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro Activity of the Ultrabroad-Spectrum-Beta-Lactamase Inhibitor QPX7728 against Carbapenem-Resistant Enterobacterales with Varying Intrinsic and Acquired Resistance Mechanisms
Kirk Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
Scott J. Hecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Interplay between β-lactamases and new β-lactamase inhibitors
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2019)
In Vitro Activity of Minocycline against US Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018
Robert K. Flamm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates
Michael Feldgarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
Krisztina M. Papp-Wallace
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Acinetobacter spp. porin Omp33-36: Classification and transcriptional response to carbapenems and host cells
Katarina Novovic et al.
PLOS ONE (2018)
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Darren Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study
Marya D. Zilberberg et al.
JOURNAL OF HOSPITAL MEDICINE (2016)
Structure-Function Relationships of Class D Carbapenemases
Jean-Denis Docquier et al.
CURRENT DRUG TARGETS (2016)
Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene
Steven J. Nigro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
IncM Plasmid R1215 Is the Source of Chromosomally Located Regions Containing Multiple Antibiotic Resistance Genes in the Globally Disseminated Acinetobacter baumannii GC1 and GC2 Clones
Grace A. Blackwell et al.
MSPHERE (2016)
Triclosan Can Select for an AdeIJK-Overexpressing Mutant of Acinetobacter baumannii ATCC 17978 That Displays Reduced Susceptibility to Multiple Antibiotics
Dinesh M. Fernando et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
The Deadly Impact of Extreme Drug Resistance in Acinetobacter baumannii*
Brad Spellberg et al.
CRITICAL CARE MEDICINE (2014)
Metallo-beta-lactamase structure and function
Timothy Palzkill
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Raffaele Zarrilli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
ISAba1 targets a specific position upstream of the intrinsic ampC gene of Acinetobacter baumannii leading to cephalosporin resistance
Mohammad Hamidian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Kazutaka Katoh et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2012)
Dissemination of New Delhi metallo-ß-lactamase-1-producing Acinetobacter baumannii in Europe
R. A. Bonnin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Copy number variation detection and genotyping from exome sequence data
Niklas Krumm et al.
GENOME RESEARCH (2012)
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Anton Bankevich et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2012)
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp.
Sebastien Coyne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Analysis of Genes Encoding Penicillin-Binding Proteins in Clinical Isolates of Acinetobacter baumannii
Rodrigo Cayo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation
Lois S. Lee et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake
Maria A. Mussi et al.
FEBS LETTERS (2007)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Jordi Vila et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
ISfinder: the reference centre for bacterial insertion sequences
P. Siguier et al.
NUCLEIC ACIDS RESEARCH (2006)
Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem
JL Kuti et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii
F Fernández-Cuenca et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
分享论文
